Status:
COMPLETED
EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS
Lead Sponsor:
Saglik Bilimleri Universitesi
Conditions:
Periodontal Health
Periodontitis Stage III
Eligibility:
All Genders
18-65 years
Brief Summary
Periodontal disease is a chronic and progressive inflammatory disease in which the hard and soft tissues that support the teeth are damaged. It is caused by the interaction between harmful bacteria an...
Detailed Description
This study was divided into 2 groups, 37 systemically and periodontally health individuals and 37 systemically healthy individuals with stage III grade B periodontitis were included. Clinical periodon...
Eligibility Criteria
Inclusion
- systemically healthy
- between the ages of 18-65
Exclusion
- Patients with systemic diseases and/or conditions that may affect periodontal tissues (cardiovascular diseases, immune system diseases, rheumatoid arthritis, diabetes mellitus, chemotherapy/radiotherapy).
- taking any medication that may have an effect on periodontal tissues,
- less than 20 natural teeth excluding third molars
- used antibiotics, anti-inflammatory or immunosuppressive drugs
- periodontal treatment in the last 6 months
- smokers
- pregnant or lactating women.
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2024
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06986044
Start Date
May 1 2023
End Date
September 15 2024
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi
Ankara, Keçiören, Turkey (Türkiye), 06010